World's Best Scientists 2026 revealed!
Hanno Glimm

Hanno Glimm

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
15382
World Ranking
14220
National Ranking
1004

Overview

Hanno Glimm is affiliated with TU Dresden in Germany and has contributed extensively to the fields of medicine, biochemistry, genetics, and molecular biology. Their research spans several specialized subfields including molecular biology, cancer research, oncology, pulmonary and respiratory medicine, and pathology and forensic medicine.

Their recent publication record highlights work on cancer genomics and diagnostics, sarcoma diagnosis and treatment, pancreatic and hepatic oncology research, lung cancer treatments and mutations, genetic factors in colorectal cancer, RNA modifications and cancer, and cancer-related molecular mechanisms research.

Notable recent papers include:

  • Sarcoma classification by DNA methylation profiling, 2021, Nature Communications
  • Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers, 2021, Cancer Discovery
  • The landscape of chromothripsis across adult cancer types, 2020, Nature Communications
  • Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study, 2020, Journal of Thoracic Oncology
  • Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer, 2021, Cell Reports

Frequent collaborators in their work include:

  • Stefan Fröhling
  • Peter Horak
  • Christoph Heining
  • Daniel Hübschmann
  • Christoph E. Heilig

Hanno Glimm's publications have appeared repeatedly in certain key venues such as:

  • Annals of Oncology (11 publications)
  • Cancer Research (9 publications)
  • Nature Communications (6 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (5 publications)
  • European Journal of Cancer (4 publications)

Their research primarily focuses on understanding molecular and genetic factors underlying various cancers. Areas like cancer genomics and diagnostics and sarcoma are especially prominent in their portfolio. The integration of genomic and transcriptomic analyses in patient care, as seen in their work guiding therapeutic decisions for rare cancers, reflects an emphasis on translational research aimed at clinical applications.

Overall, Hanno Glimm's contributions are situated at the intersection of molecular biology and clinical oncology, with a strong engagement in multi-disciplinary collaboration and publication in high-impact oncology and cancer biology journals.

Best Publications

  • Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

    Marion G Ott;Manfred Schmidt;Kerstin Schwarzwaelder;Stefan Stein

  • Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

    Stefan Stein;Marion G. Ott;Stephan Schultze-Strasser;Anna Jauch

  • An unbiased genome-wide analysis of zinc-finger nuclease specificity

    Richard Gabriel;Angelo Lombardo;Anne Arens;Jeffrey C Miller

  • Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome

    Kaan Boztug;Manfred Schmidt;Adrian Schwarzer;Pinaki P. Banerjee

  • Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

    Christian Jörg Braun;Kaan Boztug;Anna Paruzynski;Maximilian Witzel

  • High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR).

    Manfred Schmidt;Kerstin Schwarzwaelder;Cynthia Bartholomae;Karim Zaoui

  • Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.

    Joachim Weischenfeldt;Joachim Weischenfeldt;Taronish Dubash;Alexandros P Drainas;Balca R Mardin

  • Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G2/M transit and do not reenter G0

    Hanno Glimm;IL-Hoan Oh;Connie J. Eaves

  • Distinct types of tumor-initiating cells form human colon cancer tumors and metastases

    Sebastian M. Dieter;Claudia R. Ball;Christopher M. Hoffmann;Ali Nowrouzi

  • Sarcoma classification by DNA methylation profiling

    Christian Koelsche;Christian Koelsche;Daniel Schrimpf;Daniel Schrimpf;Damian Stichel;Martin Sill

  • Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy

    Annette Deichmann;Salima Hacein-Bey-Abina;Manfred Schmidt;Manfred Schmidt;Alexandrine Garrigue

  • BRAF inhibition in refractory hairy-cell leukemia.

    Sascha Dietrich;Hanno Glimm;Mindaugas Andrulis;Christof von Kalle

  • Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells

    Oksana Voloshanenko;Gerrit Erdmann;Taronish D. Dubash;Iris Augustin

  • Integrative genomic and transcriptomic analysis of leiomyosarcoma

    Priya Chudasama;Sadaf S. Mughal;Mathijs A. Sanders;Mathijs A. Sanders;Daniel Hübschmann;Daniel Hübschmann

  • Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo

    Kerstin Schwarzwaelder;Steven J. Howe;Manfred Schmidt;Manfred Schmidt;Martijn H. Brugman

  • Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-β2 microglobulin–null mice

    H. Glimm;W. Eisterer;K. Lee;J. Cashman

  • Comprehensive genomic access to vector integration in clinical gene therapy

    Richard Gabriel;Ralph Eckenberg;Anna Paruzynski;Cynthia C Bartholomae

  • NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

    Christoph Heining;Peter Horak;Sebastian Uhrig;Paula L Codo

  • Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture.

    H. Glimm;C.J. Eaves;C.J. Eaves

  • A largely random AAV integration profile after LPLD gene therapy

    Christine Kaeppel;Stuart G Beattie;Raffaele Fronza;Richard van Logtenstein

Frequent Co-Authors

Christof von Kalle
Christof von Kalle Charité - University Medicine Berlin
Benedikt Brors
Benedikt Brors German Cancer Research Center
Manfred Schmidt
Manfred Schmidt German Cancer Research Center
Albrecht Stenzinger
Albrecht Stenzinger Heidelberg University
Wilko Weichert
Wilko Weichert Technical University of Munich
Barbara Hutter
Barbara Hutter German Cancer Research Center
Peter Schirmacher
Peter Schirmacher University Hospital Heidelberg
Adrian J. Thrasher
Adrian J. Thrasher University College London
Dirk Jäger
Dirk Jäger Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Biology or Biochemistry opens several specialized and flexible pathways, especially with the rise of online education. If you’re looking to advance from a clinical support role, consider enrolling in a medical assistant to lpn bridge program online to boost your credentials in nursing.

For those seeking a comprehensive foundation in the sciences, a bs in biology online offers accelerated options and the flexibility to study from anywhere. This can be a great stepping stone toward laboratory work, graduate studies, or health professions.

Another practical route is pursuing online asn programs. These programs are ideal for students aiming to quickly enter the nursing field, often with clinical components that can be completed locally.

Those interested in health, wellness, or preventative care may opt for one of the best online nutrition degree programs. This pathway can lead to careers in dietetics, sports nutrition, or community health.

Best Scientists Citing Hanno Glimm

Trending Scientists